Cogent Biosciences Overview

Life ScienceCompany

Was Cogent Biosciences formerly PE-backed?

Yes. Cogent Biosciences was formerly owned by 1 private investor.

Where is Cogent Biosciences headquartered?

Cogent Biosciences is headquartered in Waltham, Massachusetts.

What is Cogent Biosciences’ revenue?

Cogent Biosciences disclosed revenue of 7M USD for 2020 and 22M USD for 2019.

How many employees does Cogent Biosciences have?

Cogent Biosciences has 205 employees.

What sector is Cogent Biosciences in?

Cogent Biosciences is a life science company.

When was Cogent Biosciences founded?

Cogent Biosciences was founded in 2014.

Cogent Biosciences

Cogent Biosciences, Inc.

275 Wyman Street 3rd Floor,
Waltham, Massachusetts 02451
United States,
(617) 945-5576
www.cogentbio.com

Cogent Biosciences is a biopharmaceutical company focused on developing a pipeline of novel therapies to treat cancer patients. Unum's most advanced program, PLX9486, is a highly potent and selective KIT D816V inhibitor that is being developed to treat systemic mastocytosis and GIST patients. Cogent Biosciences was founded in 2014 and is based in Waltham, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
Ladenburg Thalmann & Co.
1
Legal Deals
Goodwin Procter
1

Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.